Body composition, including changes in lean and fat mass, indicates metabolic enhancement
European Union Requires NAION Warnings for Semaglutide In June 2025, the European Medicines Agency (EMA) required semaglutide products Ozempic, Wegovy and Rybelsus to include a warning that the medications may cause a very rare increased risk of NAION
The levels of antioxidant enzymes are notably reduced in migraine patients
Obesity is a biopsychosocial disorder driven by genetics, sleep disruption, stress physiology, food environment, trauma history, and socioeconomic factors that an injection cannot touch
In the penumbra and reperfused peri-infarct region, however, MSC-derived paracrine and vasoactive signals may improve microvascular oxygen delivery and reduce hypoxia-driven glycolysis [10, 14]